Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Heroin and Nicotine Dependence
NCT01395797Phase 2Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in heroin dependence, nicotine dependence, sponsored by New York State Psychiatric Institute. Started Mar 2011; status: terminated.
02
Drugs
pioglitazone
03
Conditions
heroin dependencenicotine dependence
Beyond the preview
Go deeper on NCT01395797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395797.